Human neutrophil lipocalin: A specific marker for neutrophil activation in severe Plasmodium falciparum malaria

Acta Tropica

Volumn 87, Issue 2, 2003, Pages 279-285

  Mohammed, Abdelrahim O ^a   Elghazali, Gehad ^a,b   Mohammed, Hassabo B ^a   Elbashir, Mustafa I ^a   Xu, Shengyuan ^b   Berzins, Klavs ^c   Venge, Per ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

HNL; Lysozyme; MPO; Neutrophil; Severe malaria

Indexed keywords

LIPOCALIN;

MALARIA;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EVALUATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYSOSOME; MAJOR CLINICAL STUDY; MALARIA; NEUTROPHIL; PARASITEMIA; PLASMA; PLASMODIUM FALCIPARUM; PROTEIN BLOOD LEVEL; PULSE RATE; SAMPLE; SCHOOL CHILD; SUDAN;

PLASMODIUM FALCIPARUM;

EID: 0038771946     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00116-5     Document Type: Article

References (23)

1. Amodu O.K., Adeyemo A.A., Olumese P.E., Gbadegesin R.A. Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans. R. Soc. Trop. Med. Hyg. 92:1998;54-56.
2. Berkley J., Mwarumba S., Bramham K., Lowe B., Marsh K. Bacteraemia complicating severe malaria in children. Trans. R. Soc. Trop. Med. Hyg. 93:1999;283-286.
3. Board P.G., Losowsky M.S., Miloszewski K.J. Factor XIII, inherited and acquired deficiency. Blood Rev. 7:1993;229-242.
4. Chen L., Zhang Z.-H., Sendo F. Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clin. Exp. Immunol. 120:2000;125-133.
5. Chiwakata C.B., Hemmer C.J., Dietrich M. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect. Immun. 68:2000;394-399.
6. Hemmer C.J., Bierhaus A., von Riedesel J., Gabat S., Liliensiek B., Pitronik P., Lin J., Grauer A., et al. Elevated thrombomodulin levels as a result of endothelial involvement in Plasmodium falciparum malaria. Thromb. Haemost. 72:1994;457-464.
7. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., Waltersdorph A.M. Stimulation of neutrophils by tumor-necrosis-factor. J. Immunol. 136:1986;4220-4225.
8. Klingemann H.G., Egbring R., Holst F., Gramse M., Havemann K. Degradation of human factor XIII subunits by human granulocytic protinases. Thromb. Res. 28:1982;793-796.
9. Kumaratilake L., Ferrante A., Rzepczyk C.M. Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect. Immun. 58:1990;788-793.
10. Kumaratilake L.M., Ferrante A., Jaeger T., Rzepczyk C.M. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect. Immun. 60:1992;3731-3738.
11. Kumaratilake L.M., Ferrante A., Jaeger T., Rzepczyk C. GM-CSF-induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM-CSF and TNF. Parasite Immunol. 18:1996;115-123.
12. Kwiatkowski D., Perlmann P. Inflammatory processes in the pathogenesis of malaria. Wahlgren M., Perlmann P. Malaria: Molecular and Clinical Aspects. 1999;329-362 Harwood Academic Publishers.
13. MacPherson G.G., Warrell M.J., White N.J., Looareesuwan S., Warrell D.A. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119:1985;385-401.
14. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N., Pasvol G., Snow R. Indicators of life-threatening malaria in African children. New Engl. J. Med. 332:1995;1399-1404.
15. Mohamed A.O., Elbashir M.I., Ibrahim G., Ismail M., Venge P. Neutrophil leucocyte activation in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 90:1996;277.
16. Schofield L., Vivas L., Hackett F., Gerold P., Schwarz R.T., Tachado S. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-α-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. Ann. Trop. Med. Parasitol. 87:1993;617-626.
17. Shalaby M.R., Palladino M.A., Hirabayashi S.E., Eessalu T.E., Lewis G.D., Shepard H., Aggarwal B.B. Receptor-binding and activation of polymorphonuclear neutrophils by tumor-necrosis-factor-alpha. J. Leukocyte Biol. 41:1987;196-204.
18. Turner G. Cerebral malaria. Brain Pathol. 7:1997;569-582.
19. Wahlgren M., Treutiger C.J., Gysin J. Cytoadherence and rosetting in the pathogenesis of severe malaria. Wahlgren M., Perlmann P. Malaria: Molecular and Clinical Aspects. 1999;289-327 Harwood Academic Publishers.
20. Warrell D.A. Cerebral malaria: clinical features, pathophysiology and treatment. Ann. Trop. Med. Parasitol. 91:1997;875-884.
21. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84:(Suppl. 2):1990;1-65.
22. Xu S.Y., Carlson M., Engström Å., Garcia R., Peterson C.G.B., Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from secondary granules of human neutrophils. Scand. J. Clin. Lab. Invest. 54:1994;365-376.
23. Xu S.Y., Petersson C.G.B., Carlson M., Venge P. The development of an assay for human neutrophil lipocalin (HNL) to be used as a specific marker of neutrophil activity in vivo and vitro. J. Immunol. Methods. 171:1994;245-252.